Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
BUR's Cash to Debt is ranked higher than
85% of the 925 Companies
in the Global Biotechnology industry.

( Industry Median: 16.07 vs. BUR: No Debt )
BUR' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.92
BUR's Equity to Asset is ranked higher than
95% of the 771 Companies
in the Global Biotechnology industry.

( Industry Median: 0.65 vs. BUR: 0.92 )
BUR' s 10-Year Equity to Asset Range
Min: 0.84   Max: 0.94
Current: 0.92

0.84
0.94
Interest Coverage No Debt
BUR's Interest Coverage is ranked higher than
79% of the 439 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. BUR: No Debt )
BUR' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: 63.42
M-Score: -1.14
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -6321.88
BUR's Operating margin (%) is ranked higher than
52% of the 832 Companies
in the Global Biotechnology industry.

( Industry Median: -65.07 vs. BUR: -6321.88 )
BUR' s 10-Year Operating margin (%) Range
Min: -18770   Max: -6582.11
Current: -6321.88

-18770
-6582.11
Net-margin (%) -6014.58
BUR's Net-margin (%) is ranked higher than
52% of the 832 Companies
in the Global Biotechnology industry.

( Industry Median: -69.57 vs. BUR: -6014.58 )
BUR' s 10-Year Net-margin (%) Range
Min: -18486.67   Max: -6275.79
Current: -6014.58

-18486.67
-6275.79
ROE (%) -87.97
BUR's ROE (%) is ranked higher than
59% of the 877 Companies
in the Global Biotechnology industry.

( Industry Median: -28.59 vs. BUR: -87.97 )
BUR' s 10-Year ROE (%) Range
Min: -94.57   Max: -22.1
Current: -87.97

-94.57
-22.1
ROA (%) -78.27
BUR's ROA (%) is ranked higher than
56% of the 925 Companies
in the Global Biotechnology industry.

( Industry Median: -21.69 vs. BUR: -78.27 )
BUR' s 10-Year ROA (%) Range
Min: -89.62   Max: -21.77
Current: -78.27

-89.62
-21.77
ROC (Joel Greenblatt) (%) -882.38
BUR's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 914 Companies
in the Global Biotechnology industry.

( Industry Median: -217.20 vs. BUR: -882.38 )
BUR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1207.15   Max: -167.13
Current: -882.38

-1207.15
-167.13
EBITDA Growth (%) -15.70
BUR's EBITDA Growth (%) is ranked higher than
69% of the 621 Companies
in the Global Biotechnology industry.

( Industry Median: -8.10 vs. BUR: -15.70 )
BUR' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 49.4
Current: -15.7

0
49.4
EPS Growth (%) -14.10
BUR's EPS Growth (%) is ranked higher than
72% of the 649 Companies
in the Global Biotechnology industry.

( Industry Median: -10.10 vs. BUR: -14.10 )
BUR' s 10-Year EPS Growth (%) Range
Min: -18.1   Max: 326.4
Current: -14.1

-18.1
326.4
» BUR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

BUR Guru Trades in Q3 2013

Chuck Royce 419,903 sh (unchged)
» More
Q4 2013

BUR Guru Trades in Q4 2013

Chuck Royce 419,903 sh (unchged)
» More
Q1 2014

BUR Guru Trades in Q1 2014

Chuck Royce 419,903 sh (unchged)
» More
Q2 2014

BUR Guru Trades in Q2 2014

Chuck Royce 433,253 sh (+3.18%)
» More
» Details

Insider Trades

Latest Guru Trades with BUR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 13.90
BUR's P/B is ranked higher than
61% of the 984 Companies
in the Global Biotechnology industry.

( Industry Median: 5.80 vs. BUR: 13.90 )
BUR' s 10-Year P/B Range
Min: 0   Max: 31.3
Current: 13.9

0
31.3
EV-to-EBIT -17.18
BUR's EV-to-EBIT is ranked higher than
54% of the 984 Companies
in the Global Biotechnology industry.

( Industry Median: 9999.00 vs. BUR: -17.18 )
BUR' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -17.18

Current Ratio 8.37
BUR's Current Ratio is ranked higher than
87% of the 921 Companies
in the Global Biotechnology industry.

( Industry Median: 4.02 vs. BUR: 8.37 )
BUR' s 10-Year Current Ratio Range
Min: 1.38   Max: 55.01
Current: 8.37

1.38
55.01
Quick Ratio 8.37
BUR's Quick Ratio is ranked higher than
88% of the 921 Companies
in the Global Biotechnology industry.

( Industry Median: 3.81 vs. BUR: 8.37 )
BUR' s 10-Year Quick Ratio Range
Min: 1.38   Max: 55.01
Current: 8.37

1.38
55.01

Valuation & Return

vs
industry
vs
history
Price/Net Cash 24.07
BUR's Price/Net Cash is ranked higher than
79% of the 984 Companies
in the Global Biotechnology industry.

( Industry Median: 80.40 vs. BUR: 24.07 )
BUR' s 10-Year Price/Net Cash Range
Min: 2.6   Max: 204.5
Current: 24.07

2.6
204.5
Price/Net Current Asset Value 24.07
BUR's Price/Net Current Asset Value is ranked higher than
77% of the 984 Companies
in the Global Biotechnology industry.

( Industry Median: 41.80 vs. BUR: 24.07 )
BUR' s 10-Year Price/Net Current Asset Value Range
Min: 2.6   Max: 204.5
Current: 24.07

2.6
204.5
Price/Tangible Book 16.85
BUR's Price/Tangible Book is ranked higher than
66% of the 984 Companies
in the Global Biotechnology industry.

( Industry Median: 8.73 vs. BUR: 16.85 )
BUR' s 10-Year Price/Tangible Book Range
Min: 2.41   Max: 57.79
Current: 16.85

2.41
57.79
Forward Rate of Return (Yacktman) -14.46
BUR's Forward Rate of Return (Yacktman) is ranked higher than
72% of the 768 Companies
in the Global Biotechnology industry.

( Industry Median: -10.16 vs. BUR: -14.46 )
BUR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -14.46

Business Description

Industry: Biotechnology » Biotechnology
Compare:NVO, AMGN, GILD, BIIB, CELG » details
Traded in other countries:BU.Canada, BNE.Germany
Burcon NutraScience Corporation was founded in 1998 and is headquartered in Vancouver, Canada. The company, through its subsidiary, Burcon NutraScience (MB) Corp. is a research and development company building a portfolio of composition, application and process patents around its plant protein extraction and purification technology. The company's products include CLARISOY, a soy protein isolate, which is used in various food products, including protein shakes, power bars, soups and sauces, meats and meat analogs, and breads and baked foods; and PEAZAZZ, a soluble pea protein isolate. Its products also comprise canola protein isolates, such as Supertein that comprises albumin proteins used in beverages, confectionery, aerated desserts, and protein bars; Puratein, which consists of globulin proteins used in dressings and sauces, meat substitutes, baked goods, and protein bars.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK